Subcutaneous adipose tissue (SAT) plays a fundamental role not only in energy storage but also as an active endocrine organ, producing a diverse array of hormones known as adipokines. This study explores the spectrum of adipokines secreted by SAT, including leptin, adiponectin, resistin, and visfatin, and their roles in regulating appetite, insulin sensitivity, inflammation, and systemic metabolism. We analyzed data from 205 patients across varying metabolic health statuses, categorizing them based on theiradipokine profiles. Biochemical assays, imaging diagnostics, and lifestyle assessments were employed to explore associations between adipokine dysfunction and chronic conditions such as obesity, metabolic syndrome, and cardiovascular disease. Our results underscore the diagnostic and therapeutic potential of adipokine profiling, suggesting that targeted modulation of adipose-derived hormones could improve outcomes in metabolic disorders.
Subcutaneous adipose tissue (SAT) plays a fundamental role not only in energy storage but also as an active endocrine organ, producing a diverse array of hormones known as adipokines. This study explores the spectrum of adipokines secreted by SAT, including leptin, adiponectin, resistin, and visfatin, and their roles in regulating appetite, insulin sensitivity, inflammation, and systemic metabolism. We analyzed data from 205 patients across varying metabolic health statuses, categorizing them based on theiradipokine profiles. Biochemical assays, imaging diagnostics, and lifestyle assessments were employed to explore associations between adipokine dysfunction and chronic conditions such as obesity, metabolic syndrome, and cardiovascular disease. Our results underscore the diagnostic and therapeutic potential of adipokine profiling, suggesting that targeted modulation of adipose-derived hormones could improve outcomes in metabolic disorders.
| № | Муаллифнинг исми | Лавозими | Ташкилот номи |
|---|---|---|---|
| 1 | Babadjanova F.A. | ! | Tashkent Pediatric Medical Institute |
| 2 | Ibragimova K.. | ! | Tashkent Pediatric Medical Institute |
| № | Ҳавола номи |
|---|---|
| 1 | AhimaRS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11(8):327–332.2.Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.3.Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772–783.4.Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–2556.5.Fasshauer M, Blüher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36(7):461–470.6.Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004;255(4):439–447.7.Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319–2326. |